These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 31399349)
1. Insights on the anticandidal activity of non-antifungal drugs. Moraes DC; Ferreira-Pereira A J Mycol Med; 2019 Sep; 29(3):253-259. PubMed ID: 31399349 [TBL] [Abstract][Full Text] [Related]
2. Are the Statins promising antifungal agents against invasive candidiasis? Lima WG; Alves-Nascimento LA; Andrade JT; Vieira L; de Azambuja Ribeiro RIM; Thomé RG; Dos Santos HB; Ferreira JMS; Soares AC Biomed Pharmacother; 2019 Mar; 111():270-281. PubMed ID: 30590315 [TBL] [Abstract][Full Text] [Related]
3. Virtual screening and drug repositioning as strategies for the discovery of new antifungal inhibitors of oxidosqualene cyclase. Rabelo VW; Viegas DJ; Tucci EMN; Romeiro NC; Abreu PA J Steroid Biochem Mol Biol; 2019 Jan; 185():189-199. PubMed ID: 30193921 [TBL] [Abstract][Full Text] [Related]
4. Activity of Allyl Isothiocyanate and Its Synergy with Fluconazole against Raut JS; Bansode BS; Jadhav AK; Karuppayil SM J Microbiol Biotechnol; 2017 Apr; 27(4):685-693. PubMed ID: 28138121 [TBL] [Abstract][Full Text] [Related]
6. Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans. Cui J; Ren B; Tong Y; Dai H; Zhang L Virulence; 2015; 6(4):362-71. PubMed ID: 26048362 [TBL] [Abstract][Full Text] [Related]
7. Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens. Mamouei Z; Alqarihi A; Singh S; Xu S; Mansour MK; Ibrahim AS; Uppuluri P mSphere; 2018 Oct; 3(5):. PubMed ID: 30381356 [TBL] [Abstract][Full Text] [Related]
8. Tricyclic antidepressants inhibit Candida albicans growth and biofilm formation. Caldara M; Marmiroli N Int J Antimicrob Agents; 2018 Oct; 52(4):500-505. PubMed ID: 29990546 [TBL] [Abstract][Full Text] [Related]
9. Repurposing of Fluvastatin Against Candida albicans CYP450 Lanosterol 14 α-demethylase, a Target Enzyme for Antifungal Therapy: An In silico and In vitro Study. Rana R; Sharma R; Kumar A Curr Mol Med; 2019; 19(7):506-524. PubMed ID: 31109273 [TBL] [Abstract][Full Text] [Related]
10. Biofilm inhibition by Cymbopogon citratus and Syzygium aromaticum essential oils in the strains of Candida albicans. Khan MS; Ahmad I J Ethnopharmacol; 2012 Mar; 140(2):416-23. PubMed ID: 22326355 [TBL] [Abstract][Full Text] [Related]
11. Combination of fluconazole with non-antifungal agents: a promising approach to cope with resistant Candida albicans infections and insight into new antifungal agent discovery. Liu S; Hou Y; Chen X; Gao Y; Li H; Sun S Int J Antimicrob Agents; 2014 May; 43(5):395-402. PubMed ID: 24503221 [TBL] [Abstract][Full Text] [Related]
12. Relevance of antifungal penetration in biofilm-associated resistance of Candida albicans and non-albicans Candida species. Singh R; Kumari A; Kaur K; Sethi P; Chakrabarti A J Med Microbiol; 2018 Jul; 67(7):922-926. PubMed ID: 29767615 [TBL] [Abstract][Full Text] [Related]
13. Antifungal activity of propafenone on Barbosa AD; Leitão AC; de Oliveira LC; Rodrigues DS; de Farias Cabral VP; Moreira LEA; Silveira MJCB; Barbosa SA; de Souza BO; Sá LGDAV; de Andrade Neto JB; Cavalcanti BC; Magalhães IL; de Moraes MO; Júnior HVN; da Silva CR J Med Microbiol; 2024 Jul; 73(7):. PubMed ID: 38979984 [No Abstract] [Full Text] [Related]
14. Asarones from Acorus calamus in combination with azoles and amphotericin B: a novel synergistic combination to compete against human pathogenic Candida species in vitro. Kumar SN; Aravind SR; Sreelekha TT; Jacob J; Kumar BS Appl Biochem Biotechnol; 2015 Apr; 175(8):3683-95. PubMed ID: 25686561 [TBL] [Abstract][Full Text] [Related]
15. Antifungal susceptibilities, in vitro production of virulence factors and activities of ceragenins against Candida spp. isolated from vulvovaginal candidiasis. Hacioglu M; Guzel CB; Savage PB; Tan ASB Med Mycol; 2019 Apr; 57(3):291-299. PubMed ID: 29846682 [TBL] [Abstract][Full Text] [Related]